Blood transfusion: merits of component therapy. II. The clinical use of plasma and plasma components.
D000906:Antibodies / Q000032:analysis; D001778:Blood Coagulation Disorders / Q000628:therapy*; D001779:Blood Coagulation Factors / Q000627:therapeutic use*; D001796:Blood Protein Disorders / Q000628:therapy*; D001803:Blood Transfusion; D005164:Factor IX / Q000627:therapeutic use; D005169:Factor VIII / Q000627:therapeutic use; D006506:Hepatitis A / Q000276:immunology / Q000517:prevention & control; D006511:Hepatitis B Antigens / Q000032:analysis; D006801:Humans; D007136:Immunoglobulins / Q000627:therapeutic use; D007153:Immunologic Deficiency Syndromes / Q000628:therapy; D010949:Plasma; D012709:Serum Albumin / Q000627:therapeutic use; D065227:Transfusion Reaction
D000906:Antibodies; D001779:Blood Coagulation Factors; D006511:Hepatitis B Antigens; D007136:Immunoglobulins; D012709:Serum Albumin; D005169:Factor VIII; D005164:Factor IX